Rowland Thomas Andrew

Rowland Thomas Andrew is listed in filings as SVP at ANI Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity. Recent filings connect the profile to ANI Pharmaceuticals, Inc. (ANIP). The current snapshot covers public activity from Nov 18, 2024 to May 13, 2026. Reported amounts are shown as $36.4K to $46.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.